OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00240858

Zibo Qixiang Tengda Chemical Co Ltd

Commodity ChemicalsVerified

Zibo Qixiang Tengda Chemical Co Ltd has a debt-to-equity ratio of 1.01, indicating a capital structure that is nearly equally split between debt and equity. The company's liquidity position is characterized by a current ratio of 0.63, suggesting that its current liabilities exceed its current assets, which could pose short-term liquidity challenges. The company's cash and equivalents amount to 199.62 million CNY, which is significantly lower than its long-term debt of 11.14 billion CNY, indicating a potential liquidity risk. The company's profitability is weak, with a return on equity of -5.19% and a return on assets of -2.34%, both of which are negative and indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. These metrics are below the industry median for commodity chemicals, which typically have higher returns due to the nature of the industry. The company's operating income is negative at -636.45 million CNY, and its net income is also negative at -574.53 million CNY, further highlighting its financial distress. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and market-specific risks. The company's revenue for the latest period is 23.77 billion CNY, but the absence of detailed segment or geographic breakdown limits the ability to assess the specific drivers of its performance. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The company's operating cash flow is positive at 1.30 billion CNY, which is a positive sign, but its free cash flow is relatively low at 89.95 million CNY, indicating limited cash available for reinvestment or debt reduction. The company's capital expenditure is negative at -632.43 million CNY, suggesting a reduction in investment in long-term assets, which could impact future growth. The company faces several risk factors, including a medium liquidity risk and a potential for dilution, although the risk of dilution is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could lead to increased financial stress if not managed effectively. The company's ESG scores indicate moderate governance performance (53.88) and a high ESG controversies score (100.00), suggesting that it has not been involved in significant ESG-related controversies. Recent events, as disclosed in the company's financial statements, include a significant decline in profitability and a negative net income, which could impact investor confidence and the company's ability to secure financing. The company's financial performance and risk profile suggest that it may need to implement cost-cutting measures or seek additional financing to stabilize its operations.

30-day price · 002408-1.12 (-16.9%)
Low$5.47High$7.15Close$5.50As of22 May, 00:00 UTC
Profile
CompanyZibo Qixiang Tengda Chemical Co Ltd
Ticker002408.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Zibo Qixiang Tengda Chemical Co Ltd operates in the commodity chemicals industry, producing and selling chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Zibo Qixiang Tengda Chemical Co Ltd has a debt-to-equity ratio of 1.01, indicating a capital structure that is nearly equally split between debt and equity. The company's liquidity position is characterized by a current ratio of 0.63, suggesting that its current liabilities exceed its current assets, which could pose short-term liquidity challenges. The company's cash and equivalents amount to 199.62 million CNY, which is significantly lower than its long-term debt of 11.14 billion CNY, indicating a potential liquidity risk. The company's profitability is weak, with a return on equity of -5.19% and a return on assets of -2.34%, both of which are negative and indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. These metrics are below the industry median for commodity chemicals, which typically have higher returns due to the nature of the industry. The company's operating income is negative at -636.45 million CNY, and its net income is also negative at -574.53 million CNY, further highlighting its financial distress. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and market-specific risks. The company's revenue for the latest period is 23.77 billion CNY, but the absence of detailed segment or geographic breakdown limits the ability to assess the specific drivers of its performance. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The company's operating cash flow is positive at 1.30 billion CNY, which is a positive sign, but its free cash flow is relatively low at 89.95 million CNY, indicating limited cash available for reinvestment or debt reduction. The company's capital expenditure is negative at -632.43 million CNY, suggesting a reduction in investment in long-term assets, which could impact future growth. The company faces several risk factors, including a medium liquidity risk and a potential for dilution, although the risk of dilution is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could lead to increased financial stress if not managed effectively. The company's ESG scores indicate moderate governance performance (53.88) and a high ESG controversies score (100.00), suggesting that it has not been involved in significant ESG-related controversies. Recent events, as disclosed in the company's financial statements, include a significant decline in profitability and a negative net income, which could impact investor confidence and the company's ability to secure financing. The company's financial performance and risk profile suggest that it may need to implement cost-cutting measures or seek additional financing to stabilize its operations.
Key takeaways
  • The company has a debt-to-equity ratio of 1.01, indicating a balanced but potentially risky capital structure.
  • The company's return on equity and return on assets are both negative, indicating poor profitability and asset utilization.
  • The company's liquidity position is weak, with a current ratio of 0.63 and a negative net cash position after subtracting total debt.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to market-specific risks.
  • The company's ESG scores suggest moderate governance performance and a high ESG controversies score, indicating no significant ESG-related controversies.
  • The company's recent financial performance, including a negative net income, could impact investor confidence and the ability to secure financing.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$23.77B
Gross profit$719.4M
Operating income-$636.5M
Net income-$574.5M
R&D
SG&A
D&A
SBC
Operating cash flow$1.30B
CapEx-$632.4M
Free cash flow$89.9M
Total assets$24.52B
Total liabilities$13.45B
Total equity$11.07B
Cash & equivalents$199.6M
Long-term debt$11.14B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.07B
Net cash-$10.94B
Current ratio0.6
Debt/Equity1.0
ROA-2.3%
ROE-5.2%
Cash conversion-2.3%
CapEx/Revenue-2.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002408Activity
Op margin-2.7%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-2.4%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin3.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity101.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Social pillar41.82 (0-100)
Governance pillar53.88 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:25 UTCJob: 9089cd50